Sign In

Login

Password

Forgot Password ? Sign Up

Chloroprotyksen (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Chloroprotyksen" in Polish language version.

refsWebsite
Global rank Polish rank
12nih.gov
4th place
7th place
10doi.org
2nd place
6th place
1drugbank.ca
4,294th place
205th place
1sigmaaldrich.com
924th place
75th place
1ezdrowie.gov.pl
low place
4,812th place

doi.org

dx.doi.org

  • Christel A.S. Bergström, Kristina Luthman, Per Artursson, Accuracy of calculated pH-dependent aqueous drug solubility, „European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences”, 22 (5), 2004, s. 387–398, DOI: 10.1016/j.ejps.2004.04.006, PMID: 15265508 [dostęp 2021-03-23].
  • J.D. Dunitz, H. Eser, P. Strickler, Die Konfiguration des physiologisch wirksamen 2-Chlor-9-(?-dimethylaminopropyliden)-thioxanthens, „Helvetica Chimica Acta”, 47 (7), 1964, s. 1897–1902, DOI: 10.1002/hlca.19640470729 [dostęp 2021-03-23] (niem.).
  • Jun-Hong Ch’ng i inni, A Whole Cell Pathway Screen Reveals Seven Novel Chemosensitizers to Combat Chloroquine Resistant Malaria, „Scientific Reports”, 3, 2013, DOI: 10.1038/srep01734, PMID: 23615863, PMCID: PMC3635055 [dostęp 2021-03-23].
  • Steffen B Schulz i inni, First and second generation antipsychotics influence hippocampal gamma oscillations by interactions with 5-HT3 and D3 receptors, „British Journal of Pharmacology”, 167 (7), 2012, s. 1480–1491, DOI: 10.1111/j.1476-5381.2012.02107.x, PMID: 22817643, PMCID: PMC3514761 [dostęp 2021-03-23].
  • Neil M. Richtand i inni, Dopamine and serotonin receptor binding and antipsychotic efficacy, „Neuropsychopharmacology”, 32 (8), 2007, s. 1715–1726, DOI: 10.1038/sj.npp.1301305, PMID: 17251913 [dostęp 2021-03-23].
  • B. Fjalland, V. Boeck, Neuroleptic blockade of the effect of various neurotransmitter substances, „Acta Pharmacologica Et Toxicologica”, 42 (3), 1978, s. 206–211, DOI: 10.1111/j.1600-0773.1978.tb02191.x, PMID: 24978 [dostęp 2021-03-23].
  • M. Undén, B. Nauntofte, S. Dissing, Anticholinergic effects of cis-chlorprothixene characterized in rat parotid acini, „European Journal of Pharmacology”, 164 (1), 1989, s. 129–138, DOI: 10.1016/0014-2999(89)90239-2, PMID: 2753075 [dostęp 2021-03-23].
  • Anton A.H.P. Megens i inni, Differential interaction of neuroleptics with apomorphine-induced behavior in rats as a function of changing levels of dopamine receptor stimulation, „The Journal of Pharmacology and Experimental Therapeutics”, 347 (3), 2013, s. 681–696, DOI: 10.1124/jpet.113.207506, PMID: 24071734 [dostęp 2021-03-23].
  • B. Eberlein-König, A. Bindl, B. Przybilla, Phototoxic properties of neuroleptic drugs, „Dermatology”, 194 (2), 1997, s. 131–135, DOI: 10.1159/000246080, PMID: 9094460 [dostęp 2021-03-23].
  • M. Luisto, Polyneuropathy caused by chlorprothixene, „Acta Psychiatrica Scandinavica”, 85 (3), 1992, s. 246–248, DOI: 10.1111/j.1600-0447.1992.tb08604.x, PMID: 1314010 [dostęp 2021-03-23].

drugbank.ca

ezdrowie.gov.pl

rejestrymedyczne.ezdrowie.gov.pl

nih.gov

ncbi.nlm.nih.gov

  • Christel A.S. Bergström, Kristina Luthman, Per Artursson, Accuracy of calculated pH-dependent aqueous drug solubility, „European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences”, 22 (5), 2004, s. 387–398, DOI: 10.1016/j.ejps.2004.04.006, PMID: 15265508 [dostęp 2021-03-23].
  • M. Bagli i inni, Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparations, „Arzneimittelforschung”, 46 (3), 1996, s. 247–250, PMID: 8901143 [dostęp 2021-03-23].
  • Jun-Hong Ch’ng i inni, A Whole Cell Pathway Screen Reveals Seven Novel Chemosensitizers to Combat Chloroquine Resistant Malaria, „Scientific Reports”, 3, 2013, DOI: 10.1038/srep01734, PMID: 23615863, PMCID: PMC3635055 [dostęp 2021-03-23].
  • Steffen B Schulz i inni, First and second generation antipsychotics influence hippocampal gamma oscillations by interactions with 5-HT3 and D3 receptors, „British Journal of Pharmacology”, 167 (7), 2012, s. 1480–1491, DOI: 10.1111/j.1476-5381.2012.02107.x, PMID: 22817643, PMCID: PMC3514761 [dostęp 2021-03-23].
  • Neil M. Richtand i inni, Dopamine and serotonin receptor binding and antipsychotic efficacy, „Neuropsychopharmacology”, 32 (8), 2007, s. 1715–1726, DOI: 10.1038/sj.npp.1301305, PMID: 17251913 [dostęp 2021-03-23].
  • L. Antkiewicz-Michaluk, The influence of chronic treatment with antidepressant neuroleptics on the central serotonin system, „Polish Journal of Pharmacology and Pharmacy”, 38 (4), 1986, s. 359–370, PMID: 3774629 [dostęp 2021-03-23].
  • B. Fjalland, V. Boeck, Neuroleptic blockade of the effect of various neurotransmitter substances, „Acta Pharmacologica Et Toxicologica”, 42 (3), 1978, s. 206–211, DOI: 10.1111/j.1600-0773.1978.tb02191.x, PMID: 24978 [dostęp 2021-03-23].
  • M. Undén, B. Nauntofte, S. Dissing, Anticholinergic effects of cis-chlorprothixene characterized in rat parotid acini, „European Journal of Pharmacology”, 164 (1), 1989, s. 129–138, DOI: 10.1016/0014-2999(89)90239-2, PMID: 2753075 [dostęp 2021-03-23].
  • Anton A.H.P. Megens i inni, Differential interaction of neuroleptics with apomorphine-induced behavior in rats as a function of changing levels of dopamine receptor stimulation, „The Journal of Pharmacology and Experimental Therapeutics”, 347 (3), 2013, s. 681–696, DOI: 10.1124/jpet.113.207506, PMID: 24071734 [dostęp 2021-03-23].
  • B. Eberlein-König, A. Bindl, B. Przybilla, Phototoxic properties of neuroleptic drugs, „Dermatology”, 194 (2), 1997, s. 131–135, DOI: 10.1159/000246080, PMID: 9094460 [dostęp 2021-03-23].
  • M. Luisto, Polyneuropathy caused by chlorprothixene, „Acta Psychiatrica Scandinavica”, 85 (3), 1992, s. 246–248, DOI: 10.1111/j.1600-0447.1992.tb08604.x, PMID: 1314010 [dostęp 2021-03-23].

pubchem.ncbi.nlm.nih.gov

sigmaaldrich.com